Method Article

Development of Mouse-Derived Organoid Lines from Fallopian Tube Epithelial Cells for High Grade Serous Ovarian Carcinoma Modeling

DOI:

10.3791/68753

August 6th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol details the development of high-grade serous ovarian carcinoma (HGSOC) mouse models in vitro and in vivo. From the derivation of murine fallopian tube organoids, their genetic modification to recapitulate human HGSOC genetics, and their introduction in the ovarian bursa of syngeneic mice for in vivo development of tumors.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Effective modeling of diseases in realistic environments is crucial to improve our understanding of diverse pathologies. In this aspect, organoids offer a more faithful environment than their classical two-dimensional counterparts in vitro. Similarly, syngeneic murine models also allow researchers to investigate more complete tumor-host interactions, such as with the immune system, in vivo. Here we present a complete protocol on extracting fallopian tube epithelial cells, the cell-of-origin of high-grade serous ovarian carcinomas (HGSOC), from a mouse and derive them as primary organoid cultures, as well as their in vitro culture and maintenance. Then, we describe how to use genetic engineering techniques, such as lentiviral or retroviral gene overexpression, as well as CRISPR-Cas9 gene deletion, to modify these lines and transform them into pre-cancerous tumoroids. We also report how to use them for in vitro validation, via the extraction of genetic materials and immunofluorescence staining. Finally, we indicate how to effectively inject these tumoroids in the ovarian bursa, the autochthonous site of HGSOC, for tumor initiation.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

High-grade serous ovarian carcinoma (HGSOC) remains a poorly understood and highly lethal disease. Historically, the lack of faithful in vitro and in vivo models that represent HGSOC biology and therapy response has been a major barrier to progress. For example, multiple (if not most) studies have used cell lines that fail to share key genomic/genetic features of HGSOC, rendering questionable the relevance of their findings1,2,3,4. For example, the common ID8 syngeneic mouse model is derived from ovarian surface epithelium ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All animal tissue collection and procedures were performed ethically under the approval of the Institutional Animal Care and Use Committee (IACUC) at Alexandria Center for Life Sciences and the Perlmutter Cancer Center at NYU Langone Health, New York, New York.

1. Preparation of materials

  1. Murine organoid media (MOM) preparation
    1. Prepare the basal medium by combining the items on Table 1.
      NOTE: Media is stable for up to a month at 4 °C.
  2. 2D media preparation
    1. Combine recombinant murine EGF 50 ng/mL, Insulin-Transferrin-Selenium (final conc....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

A schematic summarizing the workflow for generating and validating HGSOC ovarian cancer is shown in Figure 1. This process begins with the extraction of fallopian tube tissue from a female C57BL/6J wild-type mouse (Figure 2A). It is recommended to start with a generous piece of tissue to ensure proper collection. Using a dissecting microscope allows for the precise isolation of the distal fallopian tube while removing surrounding tissues such as fat and the ovar.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Despite significant advancements in oncology research, HGSOC remains the most aggressive type of gynecologic malignancy and the leading cause of mortality amongst all ovarian cancers23,24. As gynecologic oncology research has evolved, so should the models used in it. Indeed, many historical ovarian cancer model cell lines have been discovered to be suboptimal to study this disease for several reasons, including genomic relevance, cell-of-origin discrepancies or l.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have no conflicts of interest to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study was supported by the National Institutes of Health under award number R01(CA257507). The schematics for the figures were created using BioRender. We want to thank Dr. Benjamin Neel for his support throughout this project, Dr. Shuang Zhang for the development of the original protocol and Dr. Kiyomi Araki for her help in optimizing it.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.25% Trypsin, 0.1% EDTA in HBSS w/o Calcium, Magnesium and Sodium BicarbonateCorning25053CI
A83-01Tocris Bioscience2939
Advanced DMEM/F12Gibco12-634-028
Aged C57BL/6J (female)The Jackson Laboratory000664
AllPrep DNA/RNA Mini KitQIAGEN80204For DNA/RNA extraction
Alt-R S.p. Cas9-GFP V3Integrated DNA Technologies10008100
Anti-Ki67 antibodyAbcamab15580
AutoClip SystemFine Science Tools12020-00For wound closure post-IBI
B-27 Supplement (50x), serum freeGibco17-504-001
Blasticidin HCl (10 mg/mL) 50 mgInvivoGenant-bl-05
Bovine Serum AlbuminSigma AldrichA9647
Buffer RLT PlusQIAGEN1053393To lyse cells before DNA/RNA extraction
Cell Recovery SolutionCorning354253
Collagenase/HyaluronidaseSTEMCELL Technologies07912
CoraLite 594-Phalloidin (red)ProteintechPF00003
Cover glass 15CIR-1Fisherbrand12-545-83
Cover glass 24 mm ´ 40 mm-1Fisherbrand12-544-12
CTS (Cell Therapy Systems) N-2 SupplementGibcoA1370701
DAPIRoche10236276001
Deoxyribonuclease I (DNAse I) from bovine pancreasSigma AldrichD5025
Difco Skim MilkBecton Dickinson232100
DispaseSTEMCELL Technologies07913
DMEM with L-Glutamine, 4.5 g/L Glucose and Sodium PyruvateCorning10013CV
DNase I recombinant, RNase-freeRoche04716728001
Dulbecco's Phosphate-Buffered SolutionSigma AldrichD8537
Dumont #5 - Ceramic Coated ForcepsFine Science Tools11252-50For fallopian tube dissection
Fetal Bovine SerumCorning35-010-CVHeat-Inactivate at 56 °C for 60 min.
Fine Scissors - ToughCutFine Science Tools14058-09For fallopian tube collection and IBI incision
Geneticin Selective Antibiotic (G418 Sulfate) (50 mg/mL)Gibco10131027
GlutaMAX Supplement (100x)Gibco35-050-061
Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Cyanine3InvitrogenA10520
Graefe ForcepsFine Science Tools11053-10For tissue handling
HEPES bufferCorning25060CI
Human R-Spondin 1 Recombinant ProteinPeproTech120-38
Insulin Syringe, U-100 0.5 mL 0.36 mm (28 G)x 12.7 mm (1/2")BDBD329461
Insulin-Transferrin-Selenium (ITS -G) (100x)Gibco41-400-045
L-Glutamine 200 mM (100x)Gibco25-030-081
Matrigel GFR Basement Membrane MatrixCorning356231BMM
Mouse EGF Recombinant ProteinPeproTech315-09
Mouse FGF-basic Recombinant ProteinPeproTech450-33
Mouse Noggin Recombinant ProteinPeproTech250-38
Mouse Wnt-3a Recombinant ProteinPeproTech315-20
N2 SupplementGibco17502048
N-acetylcysteine amideSigma AldrichA0737
Neon NxT Electroporation SystemInvitrogenNEON1SFor CRISPR-Cas9 electroporation
Neon NxT Electroporation System 10-μL Kit with 1-Channel TubesInvitrogenN1025Consumables for electroporation, including genome editing buffer
NicotinamideSigma AldrichN3376
Normal Mouse SerumInvitrogen10410
Normal Rat SerumSTEMCELL Technologies13551
Opti-MEM I Reduced Serum MediumGibco31985070
PAX8 Polyclonal antibodyProteintech10336-1-AP
Penicillin-Streptomycin (10,000 U/mL)Gibco15-140-122
PuromycinSigma AldrichP8833
Selectfrost 25 mm ´ 75 mm ´ 1.0 mmFisherbrand12-550-003
Triton X-100Fisher BioreagentsBP151
TrypLE Express Enzyme (1x), no phenol redGibco12-604-013
Vannas Spring Scissors - 4 mm Cutting EdgeFine Science Tools15019-10For fallopian tube dissection
Y27632STEMCELL Technologies72304Rho-kinase (ROCK) Inhibitor 

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Korch, C., et al. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol. Oncol. 127 (1), 241-248 (2012).
  2. Domcke, S., Sinha, R., Levine, D. A., Sander, C., Schultz, N.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Fallopian Tube OrganoidsMouse Tumor ModelOrganoid CultureGenetic EngineeringCRISPR Cas9 DeletionLentiviral OverexpressionImmune System InteractionOvarian Bursa Injection

Related Articles